The biological activity of beta-glucans;Le attività biologiche dei beta-glucani

Minerva Medica

Volumn 100, Issue 3, 2009, Pages 237-245

  Rondanelli, M ^a   Opizzi, A ^a   Monteferrario, F ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Beta glucans; Hypercholesterolemia; Immunity; Polysaccharides

Indexed keywords

BETA 1,3 GLUCAN; BETA GLUCAN; BILE ACID; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; POLYSACCHARIDE; RADIOPROTECTIVE AGENT; SHORT CHAIN FATTY ACID;

BARLEY; BILE ACID SYNTHESIS; CHOLESTEROL SYNTHESIS; DRUG MECHANISM; FERMENTATION; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNE SYSTEM; INSULIN RESPONSE; INTESTINE ABSORPTION; INTESTINE FLORA; MACROPHAGE; MUSHROOM; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OAT; REVIEW; RYE; WHEAT; YEAST;

ANIMALS; BACTERIAL INFECTIONS; BETA-GLUCANS; BLOOD GLUCOSE; CHOLESTEROL, LDL; HUMANS; HYPERLIPIDEMIAS; IMMUNE SYSTEM; INSULIN; MICE; NEOPLASMS; RADIATION INJURIES, EXPERIMENTAL; TRIGLYCERIDES;

EID: 70350076903     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 2000;5:4-27.
2. Teas J. The dietary intake of Laminaria, a brown seaweed, and breast cancer prevention. Nutr Cancer 1983;4:217-222 (Pubitemid 13136331)
3. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 1999;19:65-96.
4. Atti della Riunione Nazionale 2007 della SINU "Dalla prevenzione alla terapia nutrizionale: ruolo di carboidrati e fibra alimentare" Mirabile V.
5. Keogh GF, Cooper GJ, Mulvey TB, McArdle BH, Coles GD, Monro JA et al. Randomized controlled crossover study of the effect of a highly β-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 2003;78:711-718
6. McIntosh GH, Whyte J, McArthur R, Nestel PJ. Barley and wheat foods: influence on plasma cholesterol concentrations in hypercholesterolemic men. Am J Clin Nutr 1991;53:1205-1209
7. Behall KM, Scholfield DJ, Hallfrisch J. Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. Am J Clin Nutr 2004;80:1185-1193 (Pubitemid 41350677)
8. Keenan JM, Goulson M, Shamliyan T, Knutson N, Kolberg L, Curry L. The effects of concentrated barley beta-glucan on blood lipids in a population of hypercholesterolaemic men and women. Br J Nutr 2007;97:1162-1168 (Pubitemid 46925369)
9. Bourdon I, Yokoyama W, Davis P, Hudson C, Backus R, Richter D et al. Postprandial lipid, glucose, insulin and cholecystokinin responses in men fed barley pasta enriched with beta-glucan. Am J Clin Nutr 1999;69:55-63. (Pubitemid 29031251)
10. Casiraghi MC, Garsetti M, Testolin G, Brighenti F. Postprandial responses to cereal products enriched with barley beta-glucan. J Am Coll Nutr 2006;25:313-320 (Pubitemid 44414698)
11. Braaten JT, Wood PJ, Scott FW, Wolynetz MS, Lowe MK, Bradley-White P et al. Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994;48:465-474 (Pubitemid 24216129)
12. Maki KC, Shinnick M, Seeley MA, Veith PE, Quinn LC, Hallissey PJ et al. Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults. J Nutr 2003;133:808-813
13. Queenan KM, Stewart ML, Smith KN, Thomas W, Fulcher RG, Slavin JL. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007;6:6. (Pubitemid 46548451)
14. Reyna-Villasmil N, Bermúdez-Pirela V, Mengual-Moreno E, Arias N, Cano-Ponce C, Leal-Gonzalez E et al. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am J Ther 2007;14:203-212 (Pubitemid 46597661)
15. Miura NN, Ohno N, Aketagawa J, Tamura H, Tanaka S, Yadomae T. Blood clearance of (1→3)-beta-D-glucan in MRL lpr/lpr mice. FEMS Immunol Med Microbiol 1996;13:51-57 (Pubitemid 26036171)
16. Chihara G. Recent progress in immunopharmacology and therapeutic effects of polysaccharides. Dev Biol Stand 1992;77:191-197
17. Czop JK, Valiante NM, Janusz MJ. Phagocytosis of particulate activators of the human alternative complement pathway through monocyte beta-glucan receptors. Prog Clin Biol Res 1989;297:287-296
18. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003;197:1119-1124 (Pubitemid 36570067)
19. Frey A, Giannasca KT, Weltzin R, Giannasca PJ, Reggio H, Lencer WI et al. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med 1996;184:1045-1059 (Pubitemid 26313562)
20. Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K. Krestin (PSK). Cancer Treat Rev 1984;11:131-155
21. Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B, Forse RA. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann Surg 1994;220:601-609 (Pubitemid 24985505)
22. Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG et al. A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch Surg 1994;129:1204-10. (Pubitemid 24335973)
23. Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG et al. Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Archi Surg 1999;134:977-83. (Pubitemid 29428910)
24. Di Luzio, NR, Williams DL, McNamee RB, Malshet VG. Comparative evaluation of the tumor inhibitory and antibacterial activity of solubilized and particulate glucan. Recent Results Cancer Res 1980;75:165-172
25. Morikawa, K, Takeda R, Yamazaki M, Mizuno D. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells. Cancer Res 1985;45:1496-1501 (Pubitemid 15079093)
26. Mansell PW, Ichinose H, Reed RJ, Krementz ET, McNamee R, Di Luzio NR. Macrophage-mediated destruction of human malignant cells in vivo. J Natl Cancer Inst 1975;54:571-580
27. Sveinbjørnsson B, Rushfeldt C, Seljelid R, Smedsrød B. Inhibition of establishment and growth of mouse liver metastases after treatment with interferon gamma and beta-1,3-D-glucan. Hepatology 1998;27:1241-1248 (Pubitemid 28227850)
28. Thompson IM, Spence CR, Lamm DL, DiLuzio NR. Immunochemotherapy of bladder carcinoma with glucan and cyclophosphamide. Am J Med Sci 1987;294:294-300.
29. Wakui A, Kasai M, Konno K, Abe R, Kanamaru R, Takahashi K et al. Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group. Gan To Kagaku Ryoho 1986;13:1050-1059
30. Patchen ML, MacVittie TJ. Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan. Immunopharmacology 1983;5:303-313
31. Patchen ML, DiLuzio NR, Jacques P, MacVittie TJ. Soluble polyglycans enhance recovery from cobalt-60-induced hemopoietic injury. J Biol Response Mod 1984;3:627-633 (Pubitemid 15175575)
32. Patchen ML, MacVittie TJ, Wathen LM. Effects of pre- and post-irradiation glucan treatment on pluripotent stem cells, granulocyte, macrophage and erythroid progenitor cells, and hemopoietic stromal cells. Experientia 1984;40:1240-1244
33. Petruczenko A. Glucan effect on the survival of mice after radiation exposure. Acta Physiol Pol 1984;35:231-6. (Pubitemid 15060579)
34. Patchen ML, MacVittie TJ. Comparative effects of soluble and particulate glucans on survival in irradiated mice. J Biol Response Mod 1986;5:45-60.
35. Turnbull JL, Patchen ML, Scadden DT. The polysaccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines. Acta Haematol 1999;102:66-71.
36. Tomoda M, Ohara N, Shimizu N, Gonda R. Characterization of a novel glucan, which exhibits reticuloendothelial system-potentiating and anti-complementary activities, from the rhizome of Cnidium officinale. Chem Pharm Bull 1994;42:630-633 (Pubitemid 24156283)
37. Vetvicka V, Dvorak B, Vetvickova J, Richter J, Krizan J, Sima P, Yvin JC. Orally administered marine (1 → 3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity. Int J Biol Macromol 2007;40:291-298 (Pubitemid 46251421)
38. Mucksovaø J, Babícek K, Pospísil M. Particulate 1,3-beta-D-glucan, carboxymethylglucan and sulfoethyl-glucan - influence of their oral or intraperitoneal administration on immunological respondence of mice. Folia Microbiol (Praha) 2001;46:559-563 (Pubitemid 33638683)
39. Cramer DE, Allendorf DJ, Baran JT, Hansen R, Marroquin J, Li B et al. Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury. Blood 2006;107:835-840
40. Muller CD, Bocchini V, Giaimis J, Guerrieri P, Lombard Y, Poindron P. Functional beta-glucan receptor expression by a microglial cell line. Res Immunol 1994;145:267-275 (Pubitemid 24297396)
41. Haga S, Akai K, Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol 1989;77:569-575
42. Bolcal C, Yildirim V, Doganci S, Sargin M, Aydin A, Eken A et al. Protective effects of antioxidant medications on limb ischemia reperfusion injury. J Surg Res 2007;139:274-279 (Pubitemid 46551172)